Written by admin on December 16th, 2011
If you’ve been taking Actos, which has been reported to be the world’s top-selling diabetes drug, you should be aware of the fact that you could be at risk of developing some serious side effects. There have been a number of recent stories in the media and announcements made by the U.S. Drug Administration in [...]
Written by admin on December 9th, 2011
One of the questions that is frequently asked by people who have been exposed to asbestos is whether they are at risk of developing a cancer known as malignant mesothelioma and how and where does this cancer invade the body. Medical researchers have confirmed without a doubt over the last several decades that exposure to [...]
Written by admin on November 30th, 2011
Asbestos lawsuits have been one of the major sources of litigation in U.S. courthouses for decades and cases are still being filed, settled and debated by juries every day. And, with federal health officials estimating that about 2,000 to 3,000 Americans will be diagnosed with asbestos-caused cancers such as malignant mesothelioma for the foreseeable future [...]
Written by admin on November 10th, 2011
In the case of malignant mesothelioma health officials say it is imperative that patients with this cancer receive mesothelioma treatment and medication as soon as possible because this form of cancer – caused by exposure to asbestos – is usually very far advanced by the time it is diagnosed. This is because it usually takes [...]
Written by admin on September 7th, 2011
Bloomberg News is reporting that a recent study by medical researchers in the United Kingdom has found that firefighters who responded to the 9/11 terrorist attack sites are at nearly 20 percent more risk of developing cancer than personnel who were not at the sites. The Bloomberg story focused on the plight of a widow [...]
Written by admin on September 7th, 2011
AstraZeneca, the British maker of anti-cholesterol drug Crestor, recently pitted its popular medication in a test trial with its competitor, Pfizer’s Lipitor, and industry analysts and media observers say the results have been disastrous for AstraZeneca. The company’s shares dropped after results of clinical study it funded in an attempt to place it above its [...]
Written by admin on August 5th, 2011
Changes appear to be in the wind at the Food and Drug Administration in the wake of the massive recall of the DePuy hip implant systems and problems that have surfaced with other medical devices that had been approved by the government regulatory agency. FDA Commissioner Margaret Hamburg announced that she will make improving the [...]
Written by admin on July 29th, 2011
Nov. 19, 2010 was an important date in the long battle that consumer groups and patients have waged over the safety of Darvon, Darvocet and other painkillers that contain the opiate propoxyphene. On that date the Food and Drug Administration announced that Xanodyne Pharmaceuticals Inc. which manufacturers Darvon and Darvocet, had accepted the FDA’s request [...]
Written by admin on July 12th, 2011
More information on website pages that discuss defective drug litigation.
Written by admin on June 24th, 2011
USCPSC has issued a full and total recall of the Pourable NAPAfire and FIREGEL Gel Fuel bottles and jugs.
The pourable gel fuel can ignite unexpectedly and splatter onto people and objects nearby when it is poured into a firepot that is still burning.
This hazard can occur if the consumer does not see the flame [...]